2-127418464-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001375607.1(PROC):​c.18A>T​(p.Arg6Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.425 in 1,289,384 control chromosomes in the GnomAD database, including 118,714 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 15374 hom., cov: 32)
Exomes 𝑓: 0.42 ( 103340 hom. )

Consequence

PROC
NM_001375607.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: 1.21
Variant links:
Genes affected
PROC (HGNC:9451): (protein C, inactivator of coagulation factors Va and VIIIa) This gene encodes a vitamin K-dependent plasma glycoprotein. The encoded protein is cleaved to its activated form by the thrombin-thrombomodulin complex. This activated form contains a serine protease domain and functions in degradation of the activated forms of coagulation factors V and VIII. Mutations in this gene have been associated with thrombophilia due to protein C deficiency, neonatal purpura fulminans, and recurrent venous thrombosis.[provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-127418464-A-T is Benign according to our data. Variant chr2-127418464-A-T is described in ClinVar as [Benign]. Clinvar id is 255808.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-127418464-A-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PROCNM_000312.4 linkc.-50A>T 5_prime_UTR_variant Exon 1 of 9 ENST00000234071.8 NP_000303.1 P04070-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PROCENST00000234071.8 linkc.-50A>T 5_prime_UTR_variant Exon 1 of 9 1 NM_000312.4 ENSP00000234071.4 P04070-1

Frequencies

GnomAD3 genomes
AF:
0.438
AC:
66581
AN:
151930
Hom.:
15366
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.561
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.323
Gnomad ASJ
AF:
0.497
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.419
Gnomad FIN
AF:
0.341
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.422
Gnomad OTH
AF:
0.436
GnomAD2 exomes
AF:
0.381
AC:
52160
AN:
137010
AF XY:
0.389
show subpopulations
Gnomad AFR exome
AF:
0.564
Gnomad AMR exome
AF:
0.240
Gnomad ASJ exome
AF:
0.493
Gnomad EAS exome
AF:
0.176
Gnomad FIN exome
AF:
0.348
Gnomad NFE exome
AF:
0.424
Gnomad OTH exome
AF:
0.398
GnomAD4 exome
AF:
0.423
AC:
481127
AN:
1137336
Hom.:
103340
Cov.:
43
AF XY:
0.424
AC XY:
236561
AN XY:
557988
show subpopulations
African (AFR)
AF:
0.563
AC:
13745
AN:
24412
American (AMR)
AF:
0.243
AC:
6862
AN:
28266
Ashkenazi Jewish (ASJ)
AF:
0.495
AC:
7887
AN:
15940
East Asian (EAS)
AF:
0.168
AC:
2151
AN:
12840
South Asian (SAS)
AF:
0.436
AC:
33233
AN:
76198
European-Finnish (FIN)
AF:
0.358
AC:
4676
AN:
13062
Middle Eastern (MID)
AF:
0.493
AC:
2169
AN:
4402
European-Non Finnish (NFE)
AF:
0.427
AC:
393110
AN:
920686
Other (OTH)
AF:
0.416
AC:
17294
AN:
41530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
15249
30498
45748
60997
76246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14002
28004
42006
56008
70010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.438
AC:
66613
AN:
152048
Hom.:
15374
Cov.:
32
AF XY:
0.429
AC XY:
31886
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.561
AC:
23250
AN:
41442
American (AMR)
AF:
0.322
AC:
4929
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.497
AC:
1727
AN:
3472
East Asian (EAS)
AF:
0.174
AC:
898
AN:
5168
South Asian (SAS)
AF:
0.420
AC:
2023
AN:
4818
European-Finnish (FIN)
AF:
0.341
AC:
3604
AN:
10582
Middle Eastern (MID)
AF:
0.476
AC:
140
AN:
294
European-Non Finnish (NFE)
AF:
0.422
AC:
28687
AN:
67962
Other (OTH)
AF:
0.432
AC:
912
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1879
3758
5638
7517
9396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.439
Hom.:
2728
Bravo
AF:
0.440
Asia WGS
AF:
0.272
AC:
951
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Allele frequency is common in at least one population database (frequency: 57.719% in ExAC) based on the frequency threshold of 0.555% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. A synonymous variant not located in a splice region. -

Thrombophilia due to protein C deficiency, autosomal dominant Benign:2
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
12
DANN
Benign
0.62
PhyloP100
1.2
PromoterAI
-0.060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799810; hg19: chr2-128176040; COSMIC: COSV52166678; COSMIC: COSV52166678; API